Metabolomic Discoveries launches personalized metabolomics service Kenkodo through crowdfunding platform Indiegogo

German biotech company Metabolomic Discoveries announced the launch of personalized metabolomics tool Kenkodo. Through a smartphone app and sampling kit, users will soon be able to improve their well­being. Kenkodo is available through the crowdfunding platform Indiegogo. This product offers people the possibility to track and understand the influence of factors, such as nutrition, sports and stress on their metabolism. Through lifestyle changes, shifts in the metabolism become measurable and can be optimized accordingly. Kenkodo builds the biochemical fingerprint of every single participant.

Dr. Nicolas Schauer, CEO of Metabolomic Discoveries, is very excited about the development of Kenkodo. "Over the last couple of years we have gained a lot of knowledge and experience in metabolomics technology. It tracks more than 1000 small molecules in human samples. Metabolomics has the potential to resolve many questions regarding your wellness and your general constitution. Kenkodo will empower people to understand the effect of their daily lifestyle habits on their body. And finally, to find a lifestyle that keeps them healthy."

Every human has a different, very individual biochemical fingerprint. It combines information about our body's building blocks like amino acids or lipids and is the ultimate indicator of our level of well­being. “People respond differently to food, beverages and sports. By analyzing the metabolome of a large group of people, we will be able to make links to their lifestyle and well­being and draw meaningful conclusions, for example about food intake." says Dr. Josephine Worseck, Head of Business Development at Metabolomic Discoveries.

Dr. Isam Haddad, Bioinformatics expert at Metabolomic Discoveries, commented about Kenkodo. "We will build a predictive model that relates your lifestyle habits to your body's response. Our vision is that people will ultimately be able to recognize the metabolic pattern of a great week and repeat it by using the knowledge of Kenkodo."

For further information, please visit Kenkodo's Indiegogo campaign:
https://www.indiegogo.com/projects/track-your-metabolism-to-a-healthier-life-kenkodo

About Metabolomic Discoveries
Metabolomic Discoveries is a leading research and analytical service company. Global metabolite analysis combined with high­performance computing enables the identification of patterns. This provides deep insights into metabolism and allows to develop prediction models to live a better and healthier life.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...